Chemotherapy in head and neck carcinoma;Chemotherapie bei kopf-hals-karzinomen

Onkologe

Volumn 7, Issue 5, 2001, Pages 557-562

  Kath, R ^a  

^a Medizinische Klinik I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLIC ACID ANTAGONIST; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; TOPOTECAN;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HUMAN; LUNG METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; REMISSION; REVIEW;

EID: 0034975095     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007610170108     Document Type: Review

References (50)

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
2. Platinum analogs in recurrent and advanced head and neck cancer: A Southwest Oncology Group and Wayne State University Study
3. Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer
4. Hyperfractionated irradiation with and without concurrent chemotherapy for locally advanced head and neck cancer
5. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stage III and IV oropharynx carcinoma (ARCORO): Preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTEC)
6. A phase I-II study of cisplatin/ralitrexed (Tomudex)/LFA/ 5-FU in HNC
7. A phase II study of gemcitabine (LY 188011)in patients with advanced squamous cell carcinoma of the head and neck
8. Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck
9. Randomized comparison of cisplatin, methotrexate, bleomycin, and vincristine (VABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group
10. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for sqamous cell carcinoma of the head and neck: A phase I/II trial
11. Low toxicity and significant tumor responses in phase-II trials of carboplatin (CBDCA) in head and neck, non small cell lung, urothelial and ovarian cancers
12. Phase II trial of oxaliplatin (L-OPH) in advanced, recurrent and/or metastatic squamous-cell carcinoma of the head and neck
13. Carboplatin, an active drug in advanced head and neck cancer
14. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IVMO head and neck cancer
15. Randomized trial of neoadjuvant cisplatin and fluorouracil (CF) vs carboplatin and fluorouracil (CBDCA-F) in patients (pts) with advanced head and neck cancer
16. Adjuvant and adjunctive chemotherapy in the management of sqamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
17. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
18. Final report ora phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390)
19. Recurrent squamous-cell carcinoma of the head and neck: Overview of current and future prospects
20. A Phase III randomized trial of cisplatinum, methotrexate, cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
21. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
22. Lippen- mundhöhlen- und orophyrynxtumoren
23. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent sqamous cell carcinoma of the head and neck
24. Phase-II trial of carboplatin in aerodigestive malignancies
25. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
26. Chemotherapy in the head and neck cancer
27. Treatment of patients with recurrent or metastatic sqamous cell carcinoma of the head and neck: Current status and future directions
28. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck
29. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck
30. Docetaxel in the treatment of other solid tumors
31. Quality of life (QOL) performance in head and neck cancer (HNC): Comparison between paclitaxel-based (P-CT/XRT) and cisplatin-based (C-CT/XRT) concomitant chemoradiotherapy regimens
32. Carboplatin and methotrexate (Cb-M) as first line neoadjuvant chemotherapy in epidermoid head and neck carcinoma: An ARTAC phase-II trial
33. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: A randomized factorial phase III controlled trial
34. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer
35. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Groupo di Studio sui Tumori della Testa e del collo
36. Chemotherapy added to locoregional treatment for the head and neck squamous cell cancer. Three meta-analysis of updated individual data
37. Chemotherapy for recurrent and metastatic head and neck cancer
38. Phase II of MTA (LY231514) in advanced or recurrent sqamous cell carcinoma of the head and neck
39. The role of induction chemotherapiy in the curative treatment of squamous cell cancer of the head and neck
40. A Phase II study of oral Uracil and Ftorafur (UFT) plus Leukovorin (ORZEL) in advanced local-regional or metastatic squamous cell carcinoma of the head and neck
41. Cancer of the head and neck
42. A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies
43. High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: A randomized sudy
44. Ifosfamide in advanced head and neck cancer. A Phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group
45. A randomized prospective comparison of methotrexate, bleomycin, and cisplatin in head and neck cancer
46. Fluorouracil modulation in head and neck cancer
47. Chemotherapy for squamous cell carcinoma of head and neck: The future is now
48. Head and neck cancer
49. Antineoplastische wirksamkeit und unerwünschte nebenwirkungen der polychemotherapie ausgedehnter oro- und hypopharynxkarzinome - Ergebnisse einer prospektiven therapiestudie mit 5-Fu/Cisplatin versus 5-Fu/Carboplatin
50. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study